Literature DB >> 9251994

Mechanisms of touch-evoked pain (allodynia): a new model.

Fernando Cervero1, Jennifer M A Laird.   

Abstract

In this paper we review the current neurophysiological models of touch-evoked pain and present a new proposal that addresses the mechanisms of allodynia. The new model is based on the notion that A-beta mechanoreceptors can gain access to nociceptive neurones by means of a presynaptic link, at central level, between low threshold mechanoreceptors and nociceptors. We propose that the excitation of nociceptors provoked by a peripheral injury activates the spinal interneurones that mediate primary afferent depolarization (PAD) between low threshold mechanoreceptors and nociceptors. As a consequence of the increased and persistent barrage driving these neurones their excitability is increased such that, when activated by low threshold mechanoreceptors from areas surrounding the injury site, they produce a very intense PAD in the nociceptive afferents which is capable of generating spike activity. This activation would be conducted antidromically in the form of dorsal root reflexes (DRRs) but would also be conducted forward activating the second order neurones normally driven by nociceptors. The sensory consequence of this mechanism is pain evoked by the activation of low threshold mechanoreceptors from an area surrounding an injury site (allodynia).

Entities:  

Mesh:

Year:  1996        PMID: 9251994     DOI: 10.1016/S0304-3959(96)03165-X

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  43 in total

1.  Presynaptic alpha2-GABAA receptors in primary afferent depolarization and spinal pain control.

Authors:  Robert Witschi; Pradeep Punnakkal; Jolly Paul; Jean-Sébastien Walczak; Fernando Cervero; Jean-Marc Fritschy; Rohini Kuner; Ruth Keist; Uwe Rudolph; Hanns Ulrich Zeilhofer
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

2.  A afferent fibers are involved in the pathology of central changes in the spinal dorsal horn associated with myofascial trigger spots in rats.

Authors:  Fei Meng; Hong-You Ge; Yong-Hui Wang; Shou-Wei Yue
Journal:  Exp Brain Res       Date:  2015-07-26       Impact factor: 1.972

Review 3.  Role of cation-chloride-cotransporters (CCC) in pain and hyperalgesia.

Authors:  Theodore J Price; Fernando Cervero; Yves de Koninck
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

4.  Reversibility of central neuronal changes in patients recovering from gallbladder stones or acute cholecystitis.

Authors:  Daniel-W Kjaer; Marek Stawowy; Lars Arendt-Nielsen; Asbjorn-Mohr Drewes; Peter Funch-Jensen
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 5.  In search of lost presynaptic inhibition.

Authors:  Pablo Rudomin
Journal:  Exp Brain Res       Date:  2009-03-26       Impact factor: 1.972

6.  Chapter 9 The dorsal horn and hyperalgesia.

Authors:  Karin N Westlund
Journal:  Handb Clin Neurol       Date:  2006

7.  Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice.

Authors:  N Eguchi; T Minami; N Shirafuji; Y Kanaoka; T Tanaka; A Nagata; N Yoshida; Y Urade; S Ito; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

8.  Allodynia mediated by C-tactile afferents in human hairy skin.

Authors:  Saad S Nagi; Troy K Rubin; David K Chelvanayagam; Vaughan G Macefield; David A Mahns
Journal:  J Physiol       Date:  2011-07-04       Impact factor: 5.182

9.  Differential presynaptic control of the synaptic effectiveness of cutaneous afferents evidenced by effects produced by acute nerve section.

Authors:  P Rudomin; I Jiménez; D Chávez
Journal:  J Physiol       Date:  2013-03-11       Impact factor: 5.182

10.  Psychophysical evaluation of a sanshool derivative (alkylamide) and the elucidation of mechanisms subserving tingle.

Authors:  Kelly C Albin; Christopher T Simons
Journal:  PLoS One       Date:  2010-03-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.